![Chih Lung Shen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chih Lung Shen
Director/Board Member at
MEDEON BIODESIGN, INC.
Profile
Chih Lung Shen is the founder of Allgenesis Biotherapeutics, Inc. Current jobs include Independent Director at Medeon Biodesign, Inc. since 2015, Director at Noratech Pharmaceuticals, Inc., Director at Annji Pharmaceutical Co., Ltd. since 2019, and Managing Member at Cheng Xin Venture Capital Group.
Former jobs include Independent Director at Lotus Pharmaceutical Co., Ltd. from 2013 to 2014, Director at Mycenax Biotech, Inc., Director at Kiotek Corp., Non-Executive Director at ASLAN Pharmaceuticals Pte Ltd., Director at TWi Pharmaceuticals, Inc., Director at ARDIC Instruments Co., Director at Aslan Pharmaceuticals Ltd. from 2016 to 2018, Director at EirGenix, Inc. from 2021 to 2023, Member-Supervisory Board at TWi Pharmaceuticals, Inc. from 2012 to 2014, and Member-Supervisory Board at TWi Biotechnology, Inc. Education includes a doctorate from the University of Wisconsin and an undergraduate degree from Tsinghua University.
Chih Lung Shen active positions
| Companies | Position | Start |
|---|---|---|
| MEDEON BIODESIGN, INC. | Director/Board Member | 2015-04-19 |
| ANNJI PHARMACEUTICAL CO., LTD. | Director/Board Member | 2019-05-02 |
Cheng Xin Venture Capital Group
 Cheng Xin Venture Capital Group Investment ManagersFinance CXVCG's fund investment objective seeks superior returns. Their fund investment strategy targets firms operating primarily in biotechnology/life sciences (pharmaceuticals, medical devices, bioinformatics, healthcare services and agricultural biotechnology) and high technology (energy, electronics, optoelectronics, communications, information technology and software). They provide financing for early and expansion stage capital requirements. Investment criteria they look for include firms with a strong proprietary position, breakthrough technology responding to a large potential market, and managed by experienced entrepreneurs. They also encourage synergies of technologies or products between their portfolio firms. CXVCG looks for firms in the Asia Pacific region as well as in North America. They are active, involved investment partners. In addition to providing capital, they support their portfolio firms with the development of corporate strategy, building strategic alliances and recruitment of top management. | Investment Committee Member | - |
Noratech Pharmaceuticals, Inc. | Director/Board Member | - |
Former positions of Chih Lung Shen
| Companies | Position | End |
|---|---|---|
| EIRGENIX INC. | Director/Board Member | 2023-06-09 |
| ASLAN PHARMACEUTICALS LIMITED | Director/Board Member | 2018-10-29 |
| LOTUS PHARMACEUTICAL CO., LTD. | Director/Board Member | 2014-08-31 |
| TWI PHARMACEUTICALS INC | Director/Board Member | 2014-05-31 |
| MYCENAX BIOTECH INC. | Director/Board Member | - |
Training of Chih Lung Shen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Cheng Xin Venture Capital Group
Cheng Xin Venture Capital Group Investment ManagersFinance CXVCG's fund investment objective seeks superior returns. Their fund investment strategy targets firms operating primarily in biotechnology/life sciences (pharmaceuticals, medical devices, bioinformatics, healthcare services and agricultural biotechnology) and high technology (energy, electronics, optoelectronics, communications, information technology and software). They provide financing for early and expansion stage capital requirements. Investment criteria they look for include firms with a strong proprietary position, breakthrough technology responding to a large potential market, and managed by experienced entrepreneurs. They also encourage synergies of technologies or products between their portfolio firms. CXVCG looks for firms in the Asia Pacific region as well as in North America. They are active, involved investment partners. In addition to providing capital, they support their portfolio firms with the development of corporate strategy, building strategic alliances and recruitment of top management. | Finance |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
 Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lotus Pharmaceutical Co., Ltd.
 Lotus Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, research and sells pharmaceutical products | Health Technology |
Mycenax Biotech, Inc.
 Mycenax Biotech, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Kiotek Corp.
 Kiotek Corp. BiotechnologyHealth Technology Researches, develops and manufactures chitosan based products | Health Technology |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology Develops novel medicines for global markets | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
TWi Biotechnology, Inc.
 TWi Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops new drugs for unmet medical needs | Health Technology |
ARDIC Instruments Co. | |
Medeon Biodesign, Inc.
 Medeon Biodesign, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides medical equipments and treatment methods | Electronic Technology |
Annji Pharmaceutical Co., Ltd.
 Annji Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Engages in research and development of drugs | Health Technology |
EirGenix, Inc.
 EirGenix, Inc. BiotechnologyHealth Technology Provides biotechnology research and development services | Health Technology |
Aslan Pharmaceuticals Ltd.
 Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
Allgenesis Biotherapeutics, Inc.
 Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Noratech Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Chih Lung Shen
